1996
DOI: 10.1016/0091-3057(95)02220-1
|View full text |Cite
|
Sign up to set email alerts
|

Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
28
0

Year Published

1998
1998
2011
2011

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 57 publications
(32 citation statements)
references
References 38 publications
4
28
0
Order By: Relevance
“…Notably, NMDA agonists produce excitatory responses in cerebellar Purkinje cells and persistent inflammatory hyperalgesia and administration of progesterone attenuates these effects by reducing NMDAR activity (Ren et al, 2000;Smith, 1991). Finally, NMDARs have been localized to the ventral tegmental area (Paquet and Smith, 2000) and pharmacological manipulations of NMDARs in the ventral tegmental area elicit electrophysiological and behavioral changes in rats (Narayanan et al, 1996;Willick and Kokkinidis, 1995;Zhang et al, 1992). Together these findings suggest progestins are capable of mediating changes in NMDAR function that produce alterations in behavior and leave open the possibility that, in the ventral tegmental area, progestins may modulate NMDARs, directly or indirectly, to produce changes in lordosis of rodents.…”
Section: Introductionmentioning
confidence: 93%
“…Notably, NMDA agonists produce excitatory responses in cerebellar Purkinje cells and persistent inflammatory hyperalgesia and administration of progesterone attenuates these effects by reducing NMDAR activity (Ren et al, 2000;Smith, 1991). Finally, NMDARs have been localized to the ventral tegmental area (Paquet and Smith, 2000) and pharmacological manipulations of NMDARs in the ventral tegmental area elicit electrophysiological and behavioral changes in rats (Narayanan et al, 1996;Willick and Kokkinidis, 1995;Zhang et al, 1992). Together these findings suggest progestins are capable of mediating changes in NMDAR function that produce alterations in behavior and leave open the possibility that, in the ventral tegmental area, progestins may modulate NMDARs, directly or indirectly, to produce changes in lordosis of rodents.…”
Section: Introductionmentioning
confidence: 93%
“…It has been suggested that the primary effects of systemic MK-801 injection resemble those displayed in the ACC and VTA (33). In addition to a direct effect, MK-801 could affect the ACC indirectly by modulating dopaminergic activity in the VTA and prefrontal cortex (4).…”
Section: Discussionmentioning
confidence: 99%
“…The activity of MK-801 depends on the availability of free DA D 1 receptors (33,49,50), functional state and integrity of dopaminergic system (6), and the association between DA and excitatory amino acids that occurs postsynaptically in the ACC (5). An intact dopaminergic activity facilitates the stimulatory effects of MK-801 (51,52).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the finding that dizocilpine infusion into some brain regions decreases PPI without markedly increasing startle magnitude (DH) and that dizocilpine infusion into other regions increases startle reactivity without disrupting PPI (NAcc) indicates that perhaps different brain regions subserve these two behavioral effects of systemically administered noncompetitive NMDA antagonists (Mansbach and Geyer, 1989). Dizocilpine administration also has been reported to increase locomotor activity, most likely via a dopaminergic mechanism (French, 1986;Tricklebank et al, 1989;Lehmann-Masten and Geyer, 1991;Bubser et al, 1992;Ouagazzal et al, 1993;Ouagazzal and Amalric, 1995;Narayan et al, 1996). Although locomotor activity was not measured in the present study, it should be noted that the doses of dizocilpine required to elicit hyperactivity are generally appreciably higher than those needed to disrupt PPI, either with systemic or central administration (Mansbach and Geyer, 1989;Lehmann-Masten and Geyer, 1991;Ouagazzal and Amalric, 1995;Narayan et al, 1996).…”
Section: Figure 1 Effects On Prepulse Inhibition Of Dizocilpine Micrmentioning
confidence: 99%
“…Dizocilpine administration also has been reported to increase locomotor activity, most likely via a dopaminergic mechanism (French, 1986;Tricklebank et al, 1989;Lehmann-Masten and Geyer, 1991;Bubser et al, 1992;Ouagazzal et al, 1993;Ouagazzal and Amalric, 1995;Narayan et al, 1996). Although locomotor activity was not measured in the present study, it should be noted that the doses of dizocilpine required to elicit hyperactivity are generally appreciably higher than those needed to disrupt PPI, either with systemic or central administration (Mansbach and Geyer, 1989;Lehmann-Masten and Geyer, 1991;Ouagazzal and Amalric, 1995;Narayan et al, 1996). A few studies indicate that dizocilpine infusion into the NAcc increases locomotor activity (Ouagazzal and Amalric, 1995;Narayan et al, 1996); future studies that provide a detailed anatomical mapping of brain regions that mediate dizocilpine-induced hyperactivity will be important in clarifying the degree of homology between the neural substrates underlying dizocilpine-induced PPI deficits and hyperactivity.…”
Section: Figure 1 Effects On Prepulse Inhibition Of Dizocilpine Micrmentioning
confidence: 99%